drugset / Trial / NCT00148447

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

NCT00148447

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to evaluate the therapeutic effect of escitalopram in the treatment of negative symptoms in schizophrenia patients in a double-blind placebo-controlled study.

Timeline

Start
2004-11
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule

Indications